GeriMedRisk

 

COVID-19 is an emerging, rapidly evolving situation. Get the latest from the CDCNIH, and the Liverpool drug interaction group

 

This website, including the information available on this website (“Website”), is for informational purposes only and is not intended as, and should not be interpreted as, medical advice or other professional advice. No healthcare provider-patient relationship is created between you and GeriMedRisk through the use of this Website. Never disregard professional medical advice or delay in seeking it because of something you have read, heard, or viewed on this Website. The Website is protected by copyright law and is owned by GeriMedRisk or its licensors. Your use of the Website is at your own risk and liability. You may print or download pages of the Website for your personal, legal, non-commercial use provided that you do not modify any of the content or remove or alter any disclaimers or notices. Clinical judgement is still required. GeriMedRisk does not endorse the use of any of these therapies for COVID, but offers this information in the hopes of decreasing the risk of harmful drug-drug interactions or adverse drug events. We will do our best to update this information.

 

Potential/Off Label Investigational Treatments for Covid-19

(Updated March 30, 2021)
 

To change embedded pdf:
  1. Click "Source"
  2. Change the value of data="" to the path of the .pdf you wish to display

© Copyright 2021 GeriMedRisk. All Rights Reserved. 


COVID-19 is an emerging, rapidly evolving situation. Get the latest from CDC: https://www.coronavirus.gov and NIH: https://www.nih.gov/coronavirus  and the Liverpool drug interaction group: http://www.covid19-druginteractions.org

This document is for informational purposes only and is not intended as, and should not be interpreted as, medical advice or other professional advice. Clinical judgement is still required. GeriMedRisk does not endorse the use of any of these therapies for COVID, but offers this information in the hopes of decreasing the risk of harmful drug-drug interactions or adverse drug events. We will do our best to update this information.


Last updated: March 30, 2021 - 11: 45 AM                                                                                                                                                             Back to COVID-19 Resources